Comparative study of the efficacy of biologics vs usual treatment on OCS reduction for severe asthma patients using health insurance claim database

Trial Identifier:	D3250R00092
Sponsor:	AstraZeneca
NCTID::	NCT05136547
Start Date:	January 2022
Primary Completion Date:	May 2022
Study Completion Date:	May 2022
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Tokyo, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.